Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN)

76 filings reported holding VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share as of Q1 2022.
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) has 71 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 24.9M shares of 81.1M outstanding shares and own 30.73% of the company stock.
Largest 10 shareholders include VR Adviser, LLC (1.85M shares), BVF INC/IL (1.74M shares), Frazier Life Sciences Management, L.P. (1.74M shares), PERCEPTIVE ADVISORS LLC (1.42M shares), TCG Crossover Management, LLC (1.31M shares), Vivo Capital, LLC (1.3M shares), Paradigm Biocapital Advisors LP (1.26M shares), Deep Track Capital, LP (1.17M shares), Avidity Partners Management LP (1.04M shares), and Cormorant Asset Management, LP (1M shares).
This table shows the top 71 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.